204 related articles for article (PubMed ID: 28950711)
1. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
Zhan B; Huang X; Jiang L; Bao H; Cheng X
Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
Zhang X; Yang S; Zhang P; Fu N
Coron Artery Dis; 2020 May; 31(3):284-288. PubMed ID: 31658134
[TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of nicorandil on contrast-induced nephropathy: a meta-analysis of randomised controlled trials.
Li S; Wang L; Liu Y; Hu Q
Intern Med J; 2018 Aug; 48(8):957-963. PubMed ID: 29740934
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of nicorandil and ranolazine in prevention of contrast-induced nephropathy in patients with mild-to-moderate renal dysfunction: a randomized controlled trial.
Yusuf J; Prakash G; Safal S; Mehta V; Mukhopadhyay S
Coron Artery Dis; 2024 May; 35(3):186-192. PubMed ID: 38411168
[TBL] [Abstract][Full Text] [Related]
7. Nicorandil Reduces the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography/Intervention - Systematic Review and Meta-Analysis of Randomized Controlled Trials Including GRADE Qualification.
Pranata R; Vania R; Alkatiri AA; Firman D; Lukito AA
Cardiovasc Revasc Med; 2020 Sep; 21(9):1121-1127. PubMed ID: 31959562
[TBL] [Abstract][Full Text] [Related]
8. Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
Pranata R; Tondas AE; Vania R; Toruan MPL; Lukito AA; Siswanto BB
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1200-1212. PubMed ID: 31912996
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of brain natriuretic peptide
Mei Z; Luo S; Chen P; Zhang Q; Zhou L; Zhu C; Zhu H; Jin L
PeerJ; 2022; 10():e12975. PubMed ID: 35228908
[TBL] [Abstract][Full Text] [Related]
10. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
[TBL] [Abstract][Full Text] [Related]
11. Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
Zhang P; Li WY; Yang SC; Fu NK; Liu XG; Zhang X; Cong HL; Lin WH; Tian FS; Lu CZ; Zhang J
Angiology; 2020 Feb; 71(2):183-188. PubMed ID: 30987432
[TBL] [Abstract][Full Text] [Related]
12. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
[TBL] [Abstract][Full Text] [Related]
13. Role of Hydration in Contrast-Induced Nephropathy in Patients Who Underwent Primary Percutaneous Coronary Intervention.
Wang Z; Song Y; A G; Li Y
Int Heart J; 2019 Sep; 60(5):1077-1082. PubMed ID: 31447466
[TBL] [Abstract][Full Text] [Related]
14. Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention: a meta-analysis of 4 randomized controlled trials.
Wang X; Geng J; Zhu H; Xing C
Oncotarget; 2018 Feb; 9(14):11837-11845. PubMed ID: 29545940
[TBL] [Abstract][Full Text] [Related]
15. Evaluating biomarkers for contrast-induced nephropathy following coronary interventions: an umbrella review on meta-analyses.
Mahapatro A; Nobakht S; Mukesh S; Daryagasht AA; Korsapati AR; Jain SM; Soltani Moghadam S; Moosavi R; Javid M; Hassanipour S; Prabhu SV; Keivanlou MH; Amini-Salehi E; Nayak SS
Eur J Med Res; 2024 Apr; 29(1):210. PubMed ID: 38561791
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of short-term moderate or high-dose rosuvastatin in preventing contrast-induced nephropathy: A meta-analysis of 15 randomized controlled trials.
Liang M; Yang S; Fu N
Medicine (Baltimore); 2017 Jul; 96(27):e7384. PubMed ID: 28682890
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
[TBL] [Abstract][Full Text] [Related]
18. Oral Nicorandil effectively attenuates the incidence of contrast-induced nephropathy in patients undergoing cardiac catheterization: a randomized, controlled, open-label clinical trial.
Abdollahi Moghaddam A; Baradaran Rahimi V; Morovatdar N; Rezaee R; Babalhekam SA
Int Urol Nephrol; 2023 Sep; 55(9):2327-2334. PubMed ID: 36881267
[TBL] [Abstract][Full Text] [Related]
19. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial.
Liu Y; Chen JY; Huo Y; Ge JB; Xian Y; Duan CY; Chen SQ; Jiang W; Chen PY; Tan N;
Am Heart J; 2016 Feb; 172():88-95. PubMed ID: 26856220
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of short-term high versus low doses of atorvastatin preventing contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention.
Wu H; Li D; Fang M; Han H; Wang H
J Clin Pharmacol; 2015 Feb; 55(2):123-31. PubMed ID: 25310898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
